A recent study, however, demonstrated that Lactobacillus-derived metabolites enhance the antitumor activity of 5-FU and inhibit metastatic behavior in 5-FU-resistant colorectal cancer cells by regulating claudin-1 expression (29). This evidence concerns the gene CLDN1 and colorectal cancer.